1. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody‐Mediated Rejection and Graft Loss in Renal Allograft Recipients
- Author
-
Wehmeier, C., Hönger, G., Cun, H., Amico, P., Hirt‐Minkowski, P., Georgalis, A., Hopfer, H., Dickenmann, M., Steiger, J., and Schaub, S.
- Abstract
Panel‐reactive antibodies are widely regarded as an important immunological risk factor for rejection and graft loss. The broadness of sensitization against HLAis most appropriately measured by the “calculated population‐reactive antibodies” (cPRA) value. In this study, we investigated whether cPRArepresent an immunological risk in times of sensitive and accurate determination of pretransplantation donor‐specific HLA antibodies (DSA). Five hundred twenty‐seven consecutive transplantations were divided into four groups: cPRA0% (n = 250), cPRA1–50% (n = 129), cPRA51–100% (n = 43), and DSA(n = 105). Patients without DSAwere considered as normal risk and received standard immunosuppression without T cell–depleting induction. Patients with DSAreceived an enhanced induction therapy and maintenance immunosuppression. Surveillance biopsies were performed at 3 and 6 months. Median follow‐up was 5.7 years. Among the three cPRAgroups, there were no differences regarding the 1‐year incidence of ABMR(p = 0.16) and TCMR (p = 0.75). The 5‐year allograft survival rates were similar and around 87% (p = 0.28). The estimated glomerular filtration rateat last follow‐up was 50–53 mL/min (p = 0.45). On multivariable Cox proportional hazard analysis, the strongest independent predictor for ABMRand (death‐censored) graft survival was pretransplantation DSA. cPRAwere not predictive for ABMR,TCMR, or (death‐censored) graft survival. We conclude that with current DSAassignment, the broadness of sensitization measured by cPRAdoes not imply an immunological risk. This study investigates the impact of the broadness of sensitization measured by calculated population‐reactive antibodies on pertinent outcomes, and challenges its use as an immunological risk factor in renal allograft recipients.
- Published
- 2017
- Full Text
- View/download PDF